Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
SAR QSAR Environ Res ; 34(6): 501-521, 2023.
Article in English | MEDLINE | ID: mdl-37462112

ABSTRACT

Gastric cancer (GC) is the fifth most prevalent form of cancer worldwide. CagA - positive Helicobacter pylori infects more than 60% of the human population. Moreover, chronic infection of CagA-positive H. pylori can directly affect GC incidence. In the current study, we have repurposed FDA-approved antibiotics that are viable alternatives to current regimens and can potentially be used as combination therapy against the CagA of H. pylori. The 100 FDA-approved gram negative antibiotics were screened against CagA protein using the AutoDock 4.2 tool. Further, top nine compounds were selected based on higher binding affinity with CagA. The trajectory analysis of MD simulations reflected that binding of these drugs with CagA stabilizes the system. Nonetheless, atomic density map and principal component analysis also support the notion of stable binding of antibiotics to the protein. The residues ASP96, GLN100, PRO184, and THR185 of compound cefpiramide, doxycycline, delafloxacin, metacycline, oxytetracycline, and ertapenem were involved in the binding with CagA protein. These residues are crucial for the CagA that aids in entry or pathogenesis of the bacterium. The screened FDA-approved antibiotics have a potential druggability to inhibit CagA and reduce the progression of H. pylori borne diseases.


Subject(s)
Bacterial Proteins , Stomach Neoplasms , Humans , Anti-Bacterial Agents/pharmacology , Antigens, Bacterial/chemistry , Antigens, Bacterial/metabolism , Bacterial Proteins/chemistry , Molecular Dynamics Simulation , Oncogene Proteins/metabolism , Quantitative Structure-Activity Relationship , Stomach Neoplasms/drug therapy , Stomach Neoplasms/microbiology , Stomach Neoplasms/pathology
3.
Kathmandu Univ Med J (KUMJ) ; 12(47): 194-7, 2014.
Article in English | MEDLINE | ID: mdl-25855111

ABSTRACT

BACKGROUND: With high backlog of cataract blindness in the developing countries sutureless high volume cataract surgery is preferred surgical technique. OBJECTIVE: To report the intraoperative complications of high volume sutureless cataract surgery at secondary level eye care centre of Nepal. METHOD: This prospective study consisting 1087 eyes that underwent manual small incision cataract surgery from 2nd to 28th December 2007 at Shree Janaki Eye Hospital, Janakpur, Nepal and operated by a single eye surgeon. Preoperative and postoperative ocular findings together with intraoperative complications were carefully noted in every individual case. At post operative day one each patient was examined including uncorrected visual acuity and post operative complications which were subsequently recorded in Performa. Data were analysed using SPSS 11.5. RESULT: Sixty-three eyes (5.8%) of 1087 eyes developed intraoperative complications. Out of 63 eyes that had intra operative complications, posterior capsular rupture were seen in 42 (3.9%), sclera corneal tunnel suturing in 12 eyes (1.1%), iridodialysis 5 eyes (0.5%) and Descemet stripping in 4 eyes (0.4%). 62.1% of patients attained uncorrected visual acuity 6/18 or better and in 91.7% of eyes, there were no post operative complications. CONCLUSION: High volume suture less cataract surgery is safe surgery and should be continue in developing countries to achieve the goal of vision 2020, where there is huge backlog of cataract blindness.


Subject(s)
Cataract Extraction/adverse effects , Intraoperative Complications/epidemiology , Suture Techniques , Adolescent , Adult , Aged , Aged, 80 and over , Cataract Extraction/methods , Child , Female , Humans , Male , Middle Aged , Nepal/epidemiology , Prospective Studies , Visual Acuity , Young Adult
4.
Article in English | MEDLINE | ID: mdl-21706944

ABSTRACT

The study was done to determine the anti-tuberculosis drug resistance patterns of Mycobacterium tuberculosis (MTB) in AIDS patients. Fifty antiretroviral drug naïve new AIDS patients with clinical evidence of pulmonary tuberculosis and no previous history of tuberculosis were recruited. Baseline CD4 counts and plasma viral loads (PVL) were measured by flow cytometry and RT-PCR, respectively. Sputum samples were obtained from each patient and subjected to Ziehl-Neelsen staining and cultured on Lowenstein-Jensen medium and using the BACTEC 460 system (B460). Antimicrobial susceptibilities were tested in all isolates using the B460 gystem. The occurrence of MTB was found to be more common with a PVL>4 log10 copies/ml (odds ratio: 4.6). Of 15 MTB isolates, 8 (53.3%) had single drug resistance, 4 (26.7%) had multidrug resistance (MDR) and 1 (6.7%) had resistance to three drugs (non-MDR). Two isolates (13.3%) were sensitive to all the four drugs. Resistance to first line anti-tuberculosis drugs was found to be higher among AIDS patients with MTB.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Antitubercular Agents/pharmacology , Mycobacterium tuberculosis/drug effects , Tuberculosis, Pulmonary/drug therapy , Adult , Anti-Bacterial Agents/pharmacology , Antitubercular Agents/therapeutic use , CD4 Lymphocyte Count , Drug Resistance, Multiple, Bacterial , Ethambutol/pharmacology , Female , Humans , India/epidemiology , Isoniazid/pharmacology , Male , Mycobacterium tuberculosis/isolation & purification , Reverse Transcriptase Polymerase Chain Reaction , Rifampin/pharmacology , Sputum/microbiology , Streptomycin/pharmacology , Tuberculosis, Pulmonary/complications , Tuberculosis, Pulmonary/epidemiology , Viral Load
5.
Indian J Exp Biol ; 47(1): 53-6, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19317352

ABSTRACT

A comparative pharmacokinetic study of enrofloxacin (5 mg/kg, sc) was conducted in probenecid-pretreated (70 mg/kg, orally 1.5 h prior to enrofloxacin administration) lactating goats to assess the effect of probenecid on the kinetics of enrofloxacin. Concentration of enrofloxacin in plasma, milk and urine was estimated by microbiological assay using Escherichia coli (ATCC 25922). Minimum detection level of enrofloxacin was 0.01 microg/ml. The plasma log concentration versus time curve showed monophasic pattern and followed one compartment open model. Plasma drug concentration was significantly higher during 1-2 h in probenecid-pretreated group. Significantly higher drug concentration in milk was noted at most of the time points, while significantly lower urine drug concentration (0.083-1 h and 5-12 h) were obtained in probenecid-pretreated group. The kinetic parameters (A, B and 3) were significantly higher, while t(1/2)beta, MRT and Vd(area) were significantly lower in probenecid-pretreated group. Probenecid pretreatment decreased the urinary excretion of enrofloxacin, whereas enhanced excretion in milk which could be useful in cases of affections of udder in goats.


Subject(s)
Fluoroquinolones/pharmacokinetics , Goats/physiology , Lactation/drug effects , Probenecid/pharmacology , Animals , Enrofloxacin , Female , Fluoroquinolones/administration & dosage , Fluoroquinolones/analysis , Goats/blood , Goats/urine , Injections, Subcutaneous , Milk/chemistry , Probenecid/administration & dosage
6.
Indian J Public Health ; 53(3): 147-50, 2009.
Article in English | MEDLINE | ID: mdl-20108878

ABSTRACT

OBJECTIVES: To understand the logistics and supply management system of drugs at different levels within the district health care delivery system of Dharbanga in Bihar. METHOD: This was a cross-sectional study in 3 Primary Health Centres (PHCs), 3 Additional Primary Health Centres (APHCs) and 6 Subcentres (SCs) during September-December 2008. The study subjects were Civil Surgeon, Pharmacists, Medical Officers, ANMs. Data was collected using qualitative and quantitative techniques from different stakeholders. RESULT: The health centers were severely understaffed and drug stores are managed by unqualified/untrained pharmacists. Drug list available was not fully matching with the need/requirement of the population. The vital and essential drugs required for various health centers were of short supply or unavailable in medical stores. MOs were unaware of budget allocation/allotment for their centers. Demand estimation of the drug items were not done scientifically hence quantity of drugs supplied was not in consonance with community needs. The existing guidelines were not followed as a result drugs like Zinc, Misoprostol and Magsulf were not available at the PHCs or APHCs. The storage and transportation facilities of drugs were found to be poor. Community members were not satisfied with the availability of drugs. CONCLUSION: The logistic and supply system of drugs in Darbhanga district is very weak, hence the needs of the catering population related to medicines was not fully met.


Subject(s)
Community Health Centers/organization & administration , Pharmaceutical Preparations/supply & distribution , Pharmacies/organization & administration , Cross-Sectional Studies , Humans , India , Interviews as Topic
7.
Br J Ophthalmol ; 89(9): 1097-9, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16113356

ABSTRACT

AIM: To compare the prevalence of antibiotic resistance found in nasopharyngeal Streptococcus pneumoniae between villages treated with topical tetracycline or systemic azithromycin as part of a trachoma control programme. METHODS: All children aged 1-10 years were offered either single dose oral azithromycin treatment (20 mg/kg) or a course of topical 1% tetracycline ointment, depending on the area. Treatment was given annually for 3 years. Six months after the third annual treatment in each village, children were surveyed for nasopharyngeal carriage of S pneumoniae and resistance was determined using broth dilution MIC technique. Children in two additional villages, which had not yet been treated, were also surveyed. RESULTS: Nasopharyngeal carriage of S pneumoniae was similar in the tetracycline treated, azithromycin treated, and untreated areas (p=0.57). However, resistance to tetracycline and azithromycin was distributed differently between the three areas (p=0.004). The village treated with topical tetracycline had a higher prevalence of tetracycline resistance than the other villages (p=0.010), while the oral azithromycin treated village had a higher prevalence of macrolide resistance than the other villages (p=0.014). CONCLUSIONS: Annual mass treatment with oral azithromycin may alter the prevalence of drug resistant S pneumoniae in a community. Surprisingly, topical tetracycline may also increase nasopharyngeal pneumococcal resistance. Topical antibiotics may have an effect on extraocular bacterial resistance.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Azithromycin/administration & dosage , Nasopharynx/microbiology , Tetracycline/administration & dosage , Trachoma/drug therapy , Administration, Oral , Administration, Topical , Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , Child , Child, Preschool , Drug Administration Schedule , Drug Resistance, Bacterial , Female , Humans , Infant , Male , Nasopharyngeal Diseases/microbiology , Nepal , Ointments , Streptococcus pneumoniae/drug effects , Tetracycline/therapeutic use , Tetracycline Resistance , Time Factors
8.
Br J Ophthalmol ; 87(2): 147-8, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12543738

ABSTRACT

AIMS: To determine if macrolide resistant Streptococcus pneumoniae will be a major concern in areas that receive annual mass azithromycin distributions for trachoma. METHODS: A cross sectional survey was conducted of nasopharyngeal S pneumoniae isolates for susceptibility to azithromycin 1 year after administering a single dose of azithromycin to treat trachoma in a village in Nepal. RESULTS: S pneumoniae was isolated from 50 (86%) of 57 nasopharyngeal cultures and no resistance to azithromycin was detected. CONCLUSION: The authors were unable to demonstrate that mass azithromycin therapy for trachoma produced macrolide resistant S pneumoniae that persists until the next scheduled annual treatment.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , Streptococcus pneumoniae/drug effects , Trachoma/drug therapy , Child , Child, Preschool , Cross-Sectional Studies , Drug Resistance, Bacterial , Female , Humans , Infant , Male , Nepal/epidemiology , Prevalence , Rural Health , Streptococcal Infections/epidemiology , Trachoma/epidemiology
9.
Clin Infect Dis ; 35(4): 395-402, 2002 Aug 15.
Article in English | MEDLINE | ID: mdl-12145722

ABSTRACT

Mass administration of azithromycin to eliminate blindness due to trachoma has raised concerns regarding the emergence of antimicrobial resistance. During 2000, we compared the antimicrobial resistance of nasopharyngeal pneumococcal isolates recovered from and the prevalence of impetigo, respiratory symptoms, and diarrhea among 458 children in Nepal before and after mass administration of azithromycin. No azithromycin-resistant pneumococci were isolated except from 4.3% of children who had received azithromycin during 2 previous mass treatments (P<.001). There were decreases in the prevalence of impetigo (from 14% to 6% of subjects; adjusted odds ratio [OR], 0.41; 95% confidence interval [CI], 0.21-0.80) and diarrhea (from 32% to 11%; adjusted OR, 0.26; 95% CI, 0.14-0.43) 10 days after azithromycin treatment. The absence of macrolide-resistant isolates after 1 mass treatment with azithromycin is encouraging, although the recovery of azithromycin-resistant isolates after 2 mass treatments suggests the need for resistance monitoring when multiple rounds of antimicrobial treatment are given.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , Blindness/prevention & control , Trachoma/drug therapy , Anti-Bacterial Agents/adverse effects , Azithromycin/adverse effects , Blindness/etiology , Child , Child, Preschool , Chlamydia trachomatis/drug effects , Drug Resistance, Bacterial , Female , Gastrointestinal Diseases/etiology , Humans , Infant , Male , Nepal/epidemiology , Respiratory Tract Infections/etiology , Streptococcus pneumoniae/drug effects , Trachoma/complications , Trachoma/epidemiology
10.
Ophthalmic Epidemiol ; 8(2-3): 109-17, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11471080

ABSTRACT

With the Global Elimination of Trachoma by 2020 program underway, it has become increasingly important to identify the prevalence of ocular chlamydia infection in communities. DNA amplification tests are the gold standard, but are prohibitively expensive. In the present paper, we investigate whether pooling multiple specimens into a single test is feasible. The conjunctivae of 170 children in western Nepal were examined and swabbed. The prevalence of chlamydial infection was estimated in two ways using the ligase chain reaction: by testing all 170 specimens individually, and by testing 34 pools of 5 specimens each. We show that the confidence interval for 34 pooled specimens approaches that of doing all 170 specimens as the prevalence decreases. We also determine the optimal number of specimens to pool into a single test to minimize the confidence interval of the estimate. If the population prevalence is expected to be around 10%, then 14 specimens should be pooled per test. Even at 50% prevalence, costs can be reduced by pooling two samples per test.


Subject(s)
Chlamydia trachomatis/isolation & purification , Conjunctiva/microbiology , Specimen Handling/methods , Trachoma/epidemiology , Child , Child, Preschool , Chlamydia trachomatis/genetics , DNA, Bacterial/analysis , Humans , Infant , Ligase Chain Reaction/methods , Nepal/epidemiology , Prevalence , Rural Population , Specimen Handling/economics , Trachoma/diagnosis
11.
Bull World Health Organ ; 79(3): 194-200, 2001.
Article in English | MEDLINE | ID: mdl-11285662

ABSTRACT

OBJECTIVE: The study compares the effectiveness of two strategies for distributing azithromycin in an area with mild-to-moderate active trachoma in Nepal. METHODS: The two strategies investigated were the use of azithromycin for 1) mass treatment of all children, or 2) targeted treatment of only those children who were found to be clinically active, as well as all members of their household. FINDINGS: Mass treatment of children was slightly more effective in terms of decreasing the prevalence of clinically active trachoma (estimated by clinical examination) and of chlamydial infection (estimated by DNA amplification tests), although neither result was statistically significant. CONCLUSION: Both strategies appeared to be effective in reducing the prevalence of clinically active trachoma and infection six months after the treatment. Antibiotic treatment reduced the prevalence of chlamydial infection more than it did the level of clinically active trachoma.


Subject(s)
Anti-Bacterial Agents/supply & distribution , Anti-Bacterial Agents/therapeutic use , Azithromycin/supply & distribution , Azithromycin/therapeutic use , Trachoma/drug therapy , Child , Child Health Services/organization & administration , Child, Preschool , Humans , Infant , Nepal/epidemiology , Trachoma/epidemiology , Trachoma/prevention & control
12.
Bull World Health Organ ; 79(3): 201-7, 2001.
Article in English | MEDLINE | ID: mdl-11285663

ABSTRACT

OBJECTIVE: The present study compares the cost-effectiveness of targeted household treatment and mass treatment of children in the most westerly part of Nepal. METHODS: Effectiveness was measured as the percentage point change in the prevalence of trachoma. Resource measures included personnel time required for treatment, transportation, the time that study subjects had to wait to receive treatment, and the quantity of azithromycin used. The costs of the programme were calculated from the perspectives of the public health programme sponsor, the study subjects, and the society as a whole. FINDINGS: Previous studies have indicated no statistically significant differences in effectiveness, and the present work showed no significant differences in total personnel and transportation costs per child aged 1-10 years, the total time that adults spent waiting, or the quantity of azithromycin per child. However, the mass treatment of children was slightly more effective and used less of each resource per child aged 1-10 years than the targeted treatment of households. CONCLUSION: From all perspectives, the mass treatment of children is at least as effective and no more expensive than targeted household treatment, notwithstanding the absence of statistically significant differences. Less expensive targeting methods are required in order to make targeted household treatment more cost-effective.


Subject(s)
Anti-Bacterial Agents/economics , Azithromycin/economics , Child Health Services/organization & administration , Cost-Benefit Analysis , Trachoma/drug therapy , Anti-Bacterial Agents/supply & distribution , Anti-Bacterial Agents/therapeutic use , Azithromycin/supply & distribution , Azithromycin/therapeutic use , Child , Child Health Services/economics , Child, Preschool , Female , Health Care Costs , Humans , Infant , Male , Nepal/epidemiology , Outcome Assessment, Health Care , Trachoma/economics
15.
Bioorg Med Chem ; 7(2): 369-73, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10218830

ABSTRACT

The effect of 7,8-diacetoxy-4-methylcoumarin (DAMC) has been studied on hepatic NADPH cytochrome C reductase-- an enzyme participating in the microsomal electron transport. The preincubation of liver microsomes with DAMC resulted in a time-dependent activation of NADPH cytochrome C reductase. The catalytic activity of the enzyme enhanced nearly 600% by 25 microM concentration of DAMC after 10 min of preincubation. The action of DAMC on the reductase resulted in enhanced v(max) while Km remained constant. A plot of 1/v(max) as a function of DAMC concentration resulted in a non-linear, but rectangular hyperbola indicative of hyperbolic activation. DAMC was also proved to be effective in significantly enhancing the activity of NADPH cytochrome C reductase in vivo. 7,8-Dihydroxy-4-methylcoumarin (DHMC), the deacetylated product of DAMC failed to irreversibly activate the enzyme. The activation effect of DAMC upon the enzyme was abolished by p-hydroxymercury benzoate. The role of a transacetylase in transferring the acetyl group of DAMC to the amino acid(s) of the active site of NADPH cytochrome C reductase causing irreversible enzyme activation is enunciated.


Subject(s)
Coumarins/metabolism , Microsomes, Liver/metabolism , NADPH-Ferrihemoprotein Reductase/metabolism , Acetylation , Animals , Dose-Response Relationship, Drug , Hydroxymercuribenzoates/metabolism , Kinetics , Male , Models, Chemical , Rats , Rats, Wistar , Time Factors
16.
Bioorg Med Chem ; 6(10): 1895-904, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9839019

ABSTRACT

7,8-Diacetoxy-4-methylcoumarin (DAMC), with no prerequisite for oxidative biotransformation has been reported to produce suicide inactivation of microsomal cytochrome P-450-catalysed formation of aflatoxin B1-8,9-oxide that binds to DNA. Parenteral administration of DAMC to rats caused significant inhibition of AFB1 binding to hepatic DNA in vivo as well as AFB1-induced micronuclei formation in bone marrow cells. These results highlight the antimutagenic potential of DAMC.


Subject(s)
Aflatoxin B1/metabolism , Antimutagenic Agents/pharmacology , Coumarins/pharmacology , DNA/metabolism , Microsomes, Liver/drug effects , 7-Alkoxycoumarin O-Dealkylase/metabolism , Aflatoxin B1/pharmacology , Animals , Biotransformation , Bone Marrow Cells/drug effects , Coumarins/metabolism , Cytochrome P-450 CYP1A1/metabolism , DNA/drug effects , Dietary Supplements , Male , Micronucleus Tests , Microsomes, Liver/metabolism , Mutagens/metabolism , Rats , Time Factors
17.
Biochem Pharmacol ; 34(9): 1367-9, 1985 May 01.
Article in English | MEDLINE | ID: mdl-3994752

ABSTRACT

In a comparative study the inhibition of microsomal lipid peroxidation induced by an Fe2+-ADP-complex and NADPH by naturally occurring isoflavones and their reduced derivatives (isoflavanones and isoflavans) has been examined. It is found that the isoflavanones are more active than the parent isoflavones and the isoflavans are by far the most potent inhibitors. In our in vitro test system 6,7,4'-trihydroxy- and 6,7-dihydroxy-4'-methoxyisoflavans (IC50 values 1.3 X 10(-6) and 1.1 X 10(-6) mol/l respectively) surpass the inhibitory effect of alpha-tocopherol, (+)-cyanidanol-3 and BHA (butylated hydroxyanisole). In order to establish a structure-activity relationship, a few more isoflavans have been included in the investigation.


Subject(s)
Flavonoids/pharmacology , Isoflavones/pharmacology , Lipid Peroxides/metabolism , Microsomes, Liver/metabolism , Animals , Antioxidants/pharmacology , In Vitro Techniques , Rats , Rats, Inbred Strains
18.
Prostaglandins ; 28(6): 783-804, 1984 Dec.
Article in English | MEDLINE | ID: mdl-6441190

ABSTRACT

The effect of 6,7,4'-trihydroxyisoflavan on human platelet 12-lipoxygenase and human and porcine PMNL 5-lipoxygenase activities has been studied. 6,7,4'-Trihydroxyisoflavan was found to inhibit 5-lipoxygenase more strongly than 12-lipoxygenase; its concentration for 50% inhibition (IC50) was 1.6 microM for human and porcine 5-lipoxygenase and 22 microM for human platelet 12-lipoxygenase. Inhibition of microsomal cyclooxygenase from ram seminal vesicles is exhibited at much higher concentrations of 6,7,4'-trihydroxyisoflavan (IC50 = 200 microM).


Subject(s)
Benzopyrans/pharmacology , Blood Platelets/enzymology , Isoflavones , Lipoxygenase/blood , Neutrophils/enzymology , Animals , Arachidonate Lipoxygenases , Arachidonic Acids/blood , Arachidonic Acids/chemical synthesis , Chromatography, High Pressure Liquid , Chromatography, Thin Layer , Humans , Lipoxygenase/isolation & purification , Lipoxygenase Inhibitors , Male , Microsomes/enzymology , Prostaglandin-Endoperoxide Synthases/metabolism , Seminal Vesicles/enzymology , Sheep , Swine
19.
Biochem Pharmacol ; 33(12): 1893-5, 1984 Jun 15.
Article in English | MEDLINE | ID: mdl-6732848

ABSTRACT

The optimal conditions for the haemolysis of bovine erythrocytes by H2O2 have been established. The parameters were concentration of erythrocytes, H2O2 concentration, time, and influence of the solvent in which the substances tested were dissolved. Some inhibitors of this oxidative haemolysis have been employed to serve as model substances for further antihaemolytic investigations with natural products.


Subject(s)
Hemolysis/drug effects , Hydrogen Peroxide/pharmacology , Acetates/pharmacology , Animals , Cattle , Dose-Response Relationship, Drug , In Vitro Techniques , Phenols/pharmacology , Structure-Activity Relationship
20.
Indian J Physiol Pharmacol ; 21(1): 63-5, 1977.
Article in English | MEDLINE | ID: mdl-873593

ABSTRACT

The blood levels and tissue dispersion of sulfamoxole in poultry has been investigated. The clinical importance and public health hazards on the basis of the results obtained has been discussed.


Subject(s)
Chickens/metabolism , Sulfamoxole/analysis , Animals , Egg Yolk/analysis , Female , Kidney/analysis , Liver/analysis , Sulfamoxole/blood , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL